Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Jeffrey Cumming"'
Publikováno v:
ZooKeys, Vol 148, Iss 0, Pp 293-332 (2011)
Thirteen species of basal Brachycera (11 described as new) are reported, belonging to nine families and three infraorders. They are preserved in amber from the Early Cretaceous (Neocomian) of Lebanon, Albian of northern Spain, upper Albian to lower C
Externí odkaz:
https://doaj.org/article/df020c4028ed4497b80b7ec3fe10a2bc
Autor:
Chang Su, Yu Hou, Jielin Xu, Zhenxing Xu, Manqi Zhou, Alison Ke, Haoyang Li, Jie Xu, Matthew Brendel, Jacqueline R. M. A. Maasch, Zilong Bai, Haotan Zhang, Yingying Zhu, Molly C. Cincotta, Xinghua Shi, Claire Henchcliffe, James B. Leverenz, Jeffrey Cummings, Michael S. Okun, Jiang Bian, Feixiong Cheng, Fei Wang
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-22 (2024)
Abstract Parkinson’s disease (PD) is a serious neurodegenerative disorder marked by significant clinical and progression heterogeneity. This study aimed at addressing heterogeneity of PD through integrative analysis of various data modalities. We a
Externí odkaz:
https://doaj.org/article/c98b774780634551a2636756a95523ae
Autor:
Dale Greenwalt, Dalton Amorim, Martin Hauser, Peter Kerr, Scott Fitzgerald, Shaun Winterton, Jeffrey Cumming, Neal Evenhuis, Bradley Sinclair
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8c77c565c3d3c253d9e0c5db5e4fdb
https://doi.org/10.26879/1215
https://doi.org/10.26879/1215
Autor:
Dawn C. Matthews, Jefferson W. Kinney, Aaron Ritter, Randolph D. Andrews, Erin N. Toledano Strom, Ana S. Lukic, Lauren N. Koenig, Carolyn Revta, Howard M. Fillit, Kate Zhong, Babak Tousi, James B. Leverenz, Howard H. Feldman, Jeffrey Cummings
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 10, Iss 3, Pp n/a-n/a (2024)
Abstract INTRODUCTION The “A/T/N” (amyloid/tau/neurodegeneration) framework provides a biological basis for Alzheimer's disease (AD) diagnosis and can encompass additional changes such as inflammation (“I”). A spectrum of T/N/I imaging and pl
Externí odkaz:
https://doaj.org/article/928ea7d24f9142e28dbc79c4984a4006
Autor:
Pierre N. Tariot, Mercè Boada, Krista L. Lanctôt, Julie Hahn-Pedersen, Firas Dabbous, Sariya Udayachalerm, Lars Lau Raket, Yuliya Halchenko, Wojciech Michalak, Wendy Weidner, Jeffrey Cummings
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-13 (2024)
Abstract Background Understanding the relationship among changes in Clinical Dementia Rating (CDR), patient outcomes, and probability of progression is crucial for evaluating the long-term benefits of disease-modifying treatments. We examined associa
Externí odkaz:
https://doaj.org/article/5d978327cf5b4c69ae31dda83ddacfdb
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 10, Iss 2, Pp n/a-n/a (2024)
Abstract INTRODUCTION New therapies to prevent or delay the onset of symptoms, slow progression, or improve cognitive and behavioral symptoms of Alzheimer's disease (AD) are needed. METHODS We interrogated clinicaltrials.gov including all clinical tr
Externí odkaz:
https://doaj.org/article/125a19a3ab2341c8adc5e8993673bed6
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-13 (2023)
Abstract Background Development of in vivo biomarkers has shifted the diagnosis of Alzheimer’s disease (AD) from the later dementia stages of disease towards the earlier stages and has introduced the potential for pre-symptomatic diagnosis. The Int
Externí odkaz:
https://doaj.org/article/6ef378f488594f9284b13f978bebc207
Autor:
Krista L. Lanctôt, Mercè Boada, Pierre N. Tariot, Firas Dabbous, Julie Hahn‐Pedersen, Sariya Udayachalerm, Lars Lau Raket, Cynthia Saiontz‐Martinez, Wojciech Michalak, Wendy Weidner, Jeffrey Cummings
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 16, Iss 1, Pp n/a-n/a (2024)
Abstract INTRODUCTION We examined associations between the Clinical Dementia Rating Scale (CDR) and function (Functional Assessment Scale [FAS]), neuropsychiatric symptoms (Neuropsychiatric Inventory Questionnaire [NPI‐Q]), and cognitive impairment
Externí odkaz:
https://doaj.org/article/439da02a121f44439d983700c601118d
Autor:
Randall J. Bateman, Jeffrey Cummings, Scott Schobel, Stephen Salloway, Bruno Vellas, Mercè Boada, Sandra E. Black, Kaj Blennow, Paulo Fontoura, Gregory Klein, Sheila Seleri Assunção, Janice Smith, Rachelle S. Doody
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-17 (2022)
Abstract Background This review describes the research and development process of gantenerumab, a fully human anti-amyloid monoclonal antibody in development to treat early symptomatic and asymptomatic Alzheimer’s disease (AD). Anti-amyloid monoclo
Externí odkaz:
https://doaj.org/article/701ae4d81db149459c1e8185bf10abd2
Autor:
Jeffrey Cummings, Julie Hviid Hahn-Pedersen, Christian Stefan Eichinger, Caroline Freeman, Alice Clark, Luis Rafael Solís Tarazona, Krista Lanctôt
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundPeople with Alzheimer’s disease (AD) have difficulties in performing activities of daily living (ADLs) as the disease progresses, commonly experience neuropsychiatric symptoms (NPS), and often have comorbidities such as cardiovascular dis
Externí odkaz:
https://doaj.org/article/665660399363400781a1f65acc5b782c